Results 21 to 30 of about 93,891 (304)
Circulation, 1954 A review of selected papers on myocarditis published during the past decade and an analysis of some original data together with personal experiences have been presented. All of these indicate that the clinical diagnosis of myocarditis is made far too infrequently as contrasted with the high incidence of this disease as recognized by ...
C E, DE LA CHAPELLE, C E, KOSSMANN
openaire +2 more sources
Frontiers in Immunology, 2022 Background and ObjectiveImmune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems.
Xiaohong Xie +16 more
doaj +1 more source
COVID myocarditis: a review of the literature
Monaldi Archives for Chest Disease, 2023 Myocarditis is a potentially fatal complication of coronavirus disease 2019 (COVID‐19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. COVID‐19 myocarditis appears to have distinct inflammatory characteristics
Angelica Cersosimo +4 more
doaj +1 more source
The Lancet, 2012 Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease ...
Sandeep, Sagar +2 more
openaire +2 more sources
Electrocardiographic features of immune checkpoint inhibitor-associated myocarditis. [PDF]
, 2022 Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myocarditis, whilst improving cancer-related outcomes.
Song, Wenhua +10 more
core +1 more source
COVID-19 and myocarditis: a review of literature
The Egyptian Heart Journal, 2022 Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.
Mohammed Ali +8 more
doaj +1 more source
Immune mechanisms of group B coxsackievirus induced viral myocarditis
Virulence, 2023 Viral myocarditis is known to be a primary cause of dilated cardiomyopathy (DCM) that can lead to heart failure and sudden cardiac death and is invariably caused by myocardial viral infection following active inflammatory destruction of the myocardium ...
Yue Zhang +4 more
doaj +1 more source
Inflammatory cardiomyopathy - diagnosis and risk stratification in myocarditis [PDF]
, 2020 Background: Acute myocarditis remains a challenging clinical diagnosis with limited epidemiological data and poorly defined markers of adverse risk. We sought to build a better understanding of myocarditis epidemiology and to integrate clinical, genetic
Lota, Amrit S.
core +1 more source
Frontiers in Cardiovascular Medicine, 2021 Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually ...
Yongwhan Lim +6 more
doaj +1 more source
Diagnostics, 2022 Viral myocarditis is inflammation of the myocardium secondary to viral infection. The clinical presentation of viral myocarditis is very heterogeneous and can range from nonspecific symptoms of malaise and fatigue in subclinical disease to a more florid ...
Adedayo Adeboye +4 more
doaj +1 more source